Spyre Therapeutics (SYRE) Current Leases (2019 - 2023)
Spyre Therapeutics (SYRE) posted Current Leases of $4.3 million for Q2 2023, up 612.34% on a QoQ basis from $608000.0 in Q1 2023, and up 807.97% year-over-year from $477000.0 in Q2 2022.
Spyre Therapeutics (SYRE) Current Leases (2019 - 2023) Analysis & Trends
Spyre Therapeutics' Current Leases history runs 5 years deep, the most recent figure standing at $4.3 million for Q2 2023.
- Quarterly Current Leases rose 807.97% year-over-year to $4.3 million in Q2 2023, while the trailing twelve-month figure through Jun 2023 was $4.3 million (up 807.97% YoY) and the FY2022 annual result came in at $625000.0, up 43.35% from the prior year.
- Current Leases was $4.3 million for Q2 2023 at Spyre Therapeutics, up from $608000.0 in the prior quarter.
- Across five years, Current Leases topped out at $4.3 million in Q2 2023 and bottomed at $228000.0 in Q2 2020.
- A 5-year average of $618277.8 and a median of $381500.0 in 2019 frame the typical range for Current Leases.
- Annual changes were most pronounced in 2020 — Current Leases sank 30.49% — and 2023, when it surged 807.97%.
- Spyre Therapeutics' Current Leases stood at $351000.0 in 2019, then declined by 9.12% to $319000.0 in 2020, then surged by 36.68% to $436000.0 in 2021, then soared by 43.35% to $625000.0 in 2022, then surged by 592.96% to $4.3 million in 2023.
- Business Quant data shows SYRE's Current Leases at $4.3 million in Q2 2023, $608000.0 in Q1 2023, and $625000.0 in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 20.58 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 872,589.03 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 11.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.61 Mn |
| 10 | Spyre Therapeutics | 257.83 Mn | 257.83 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 4.33 Mn |
| Mar 31, 2023 | 608,000.00 |
| Dec 31, 2022 | 625,000.00 |
| Sep 30, 2022 | 587,000.00 |
| Jun 30, 2022 | 477,000.00 |
| Mar 31, 2022 | 457,000.00 |
| Dec 31, 2021 | 436,000.00 |
| Sep 30, 2021 | 415,000.00 |
| Jun 30, 2021 | 412,000.00 |
| Mar 31, 2021 | 315,000.00 |
| Dec 31, 2020 | 319,000.00 |
| Sep 30, 2020 | 341,000.00 |
| Jun 30, 2020 | 228,000.00 |
| Mar 31, 2020 | 293,000.00 |
| Dec 31, 2019 | 351,000.00 |
| Sep 30, 2019 | 289,000.00 |
| Jun 30, 2019 | 328,000.00 |
| Mar 31, 2019 | 317,000.00 |